Table 5

Histological follow-up findings of patients with atypical glandular cells of undetermined significance-not otherwise specified (AGUS-NOS) compared to the results of other studies with AGUS including subqualifications (reactive/neoplastic/NOS) [18].

FOLLOWING-UP FINDINGS

STUDY

NUMBER OF AGUS-cases

BENIGN (%)

ADENOCARCINOMA (%)

SIL*** (%)


BASE et al19 (1994)

44

9 (20)

0 (0)

35 (80)

BURJA et al20 (1999)

64

26 (41)

3 (5)

35 (54)

DUSKA et al21 (1998)

73

48 (66)

19 (26)

6 (8)

KENNEDY et al22 (1996)

77

60 (78)

10 (13)

7 (9)

JONES and NOVIS8 (1996)

293*

141 (48)

13 (4.5)

116 (40)

RAAB et al23 (1997)

116

50 (43)

16 (14)

50 (43)

SOOFER and SIDAWY18 (2000)

69

52 (75)

7 (10)

10 (15)

OUR SERIES

183**

80 (44)

66 (36)

28 (15)


* The remaining 7.5% of patients had combinations or other significant lesions. ** The remaining 5.0% of patients had other significant lesions i.e. 3 endometrial adenomatous hyperplasias; 3 metastatic vaginal (2) and ovarian (1) adenocarcinomas; 3 invasive endocervical squamous carcinomas. *** SIL: squamous intraepithelial lesions.

Scheiden et al. BMC Cancer 2004 4:37   doi:10.1186/1471-2407-4-37

Open Data